Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
AstraZeneca
Cantor Fitzgerald
QuintilesIMS
McKinsey
Johnson and Johnson
Moodys
Fish and Richardson
Fuji
Baxter

Generated: February 21, 2018

DrugPatentWatch Database Preview

BIMATOPROST Drug Profile

« Back to Dashboard

When do Bimatoprost patents expire, and what generic alternatives are available?

Bimatoprost is a drug marketed by Apotex Inc, Lupin Ltd, and Sandoz Inc. and is included in five NDAs.

The generic ingredient in BIMATOPROST is bimatoprost. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the bimatoprost profile page.
Summary for BIMATOPROST
Drug patent expirations by year for BIMATOPROST
Pharmacology for BIMATOPROST
Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog
Medical Subject Heading (MeSH) Categories for BIMATOPROST

US Patents and Regulatory Information for BIMATOPROST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc BIMATOPROST bimatoprost SOLUTION/DROPS;OPHTHALMIC 090449-001 Jul 20, 2015 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc BIMATOPROST bimatoprost SOLUTION/DROPS;TOPICAL 201894-001 Dec 1, 2014 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Ltd BIMATOPROST bimatoprost SOLUTION/DROPS;OPHTHALMIC 203991-001 Feb 20, 2015 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc BIMATOPROST bimatoprost SOLUTION/DROPS;OPHTHALMIC 202565-001 May 5, 2015 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc BIMATOPROST bimatoprost SOLUTION/DROPS;TOPICAL 202719-001 Apr 19, 2016 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Deloitte
Fish and Richardson
Boehringer Ingelheim
Julphar
Baxter
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot